Taryn A Eubank
Impact in
-
- Clostridium difficile and Clostridium perfringens research
- Antimicrobial Resistance in Staphylococcus
- Viral gastroenteritis research and epidemiology
Papers in
-
- Clostridium difficile and Clostridium perfringens research 11
- Antimicrobial Resistance in Staphylococcus 5
- Antifungal resistance and susceptibility 2
- Viral gastroenteritis research and epidemiology 2
-
- Microscopic Colitis 2
- Co-authors
- Kevin W. Garey (15 shared papers)Anne J Gonzales-Luna (7 shared papers)Katherine K. Perez (1 shared paper)Julian G. Hurdle (4 shared papers)Chetna Dureja (2 shared papers)Eugénie Bassères (1 shared paper)Khurshida Begum (4 shared papers)Trang Le (2 shared papers)
- Journals
- Open Forum Infectious Diseases (5 papers)Antimicrobial Agents and Chemotherapy (2 papers)The Journal of Infectious Diseases (2 papers)Antibiotics (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesPhilippinesThailand
In The Last Decade
Taryn A Eubank
14 papers receiving 130 citations
Peers
Comparison fields: 5 of 39
- Applied Microbiology and Biotechnology 9
- Infectious Diseases 78
- Clinical Biochemistry 21
- Gastroenterology 13
- Critical Care and Intensive Care Medicine 8
Countries citing papers authored by Taryn A Eubank
This map shows the geographic impact of Taryn A Eubank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taryn A Eubank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taryn A Eubank more than expected).
Fields of papers citing papers by Taryn A Eubank
This network shows the impact of papers produced by Taryn A Eubank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taryn A Eubank. The network helps show where Taryn A Eubank may publish in the future.
Co-authors
The 25 scholars most cited alongside Taryn A Eubank, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 39 | |
| 2 | 2022 | 30 | |
| 3 | 2024 | 15 | |
| 4 | 2024 | 15 | |
| 5 | 2023 | 7 | |
| 6 | 2021 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 3 | |
| 10 | 2024 | 3 | |
| 11 | 2025 | 2 | |
| 12 | 2025 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2025 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2024 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Taryn A Eubank
Taryn A Eubank is a scholar working on Infectious Diseases, Epidemiology, Surgery, Critical Care and Intensive Care Medicine and Molecular Medicine, having authored 19 papers that have together received 132 indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (11 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Helicobacter pylori-related gastroenterology studies (3 papers), Antibiotic Use and Resistance (2 papers), Antifungal resistance and susceptibility (2 papers), Microscopic Colitis (2 papers), Viral gastroenteritis research and epidemiology (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (9 citations), Infectious Diseases (78 citations), Clinical Biochemistry (21 citations), Gastroenterology (13 citations) and Critical Care and Intensive Care Medicine (8 citations). Taryn A Eubank has collaborated with scholars based in United States, Philippines and Thailand. Frequent co-authors include Kevin W. Garey, Anne J Gonzales-Luna, Katherine K. Perez, Julian G. Hurdle, Chetna Dureja, Eugénie Bassères, Khurshida Begum, Trang Le, Xinyun Cao and Chenlin Hu. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases, Antibiotics and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.